CRESEMBA
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0469-0420 -
Package NDC
0469-0420-01 -
Application number
NDA207501 -
SPL ID
7e6e45d4-9266-4451-b6b6-0d054bbcab63 -
SPL set ID
8f7f73b8-586a-4df0-935f-fecd4696c16c -
UNII
31Q44514JV -
RxCUI
1608327 -
RxCUI
1608333 -
RxCUI
1608811 -
RxCUI
1608815 -
RxCUI
2623470 -
RxCUI
2623472
What the source publishes
- Labeler
- Astellas Pharma US, Inc.
- Active ingredients
- isavuconazonium sulfate
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "CRESEMBA",
"splId": "7e6e45d4-9266-4451-b6b6-0d054bbcab63",
"labels": [
{
"setId": "8f7f73b8-586a-4df0-935f-fecd4696c16c",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f7f73b8-586a-4df0-935f-fecd4696c16c",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8f7f73b8-586a-4df0-935f-fecd4696c16c"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Astellas Pharma US, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0469-0420-01) / 5 mL in 1 VIAL, SINGLE-DOSE",
"package_ndc": "0469-0420-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20150306"
}
],
"productId": "0469-0420_7e6e45d4-9266-4451-b6b6-0d054bbcab63",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"productNdc": "0469-0420",
"deaSchedule": null,
"genericName": "isavuconazonium sulfate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ISAVUCONAZONIUM SULFATE",
"strength": "40 mg/mL"
}
],
"applicationNumber": "NDA207501",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20150306",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"31Q44514JV"
],
"rxcui": [
"1608327",
"1608333",
"1608811",
"1608815",
"2623470",
"2623472"
],
"spl_set_id": [
"8f7f73b8-586a-4df0-935f-fecd4696c16c"
],
"manufacturer_name": [
"Astellas Pharma US, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0469-0420_7e6e45d4-9266-4451-b6b6-0d054bbcab63"